Literature DB >> 27012275

Vertical Transmission of Histoplasmosis Associated With Anti-Tumor Necrosis Factor Therapy.

James G Carlucci1, Natasha Halasa1, C Buddy Creech1, Daniel E Dulek1, Oscar G Gómez-Duarte1, George E Nelson2, H Keipp Talbot2, Melissa L Scalise3, Patricia L Scott4, Uma Mahadevan5, Dawn B Beaulieu6.   

Abstract

Therapeutics blocking the activity of tumor necrosis factor (anti-TNF) are a risk factor for invasive fungal infections; however, infectious risks to infants born to mothers receiving anti-TNF therapy are not well defined. We report a case of vertical transmission of disseminated histoplasmosis in a mother-infant pair exposed to anti-TNF therapy.
© The Author 2016. Published by Oxford University Press on behalf of the Pediatric Infectious Diseases Society. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  histoplasmosis; immunocompromised host; infant; tumor necrosis factor; vertical transmission

Mesh：

Substances：

Year:  2016        PMID： 27012275      PMCID： PMC6280983          DOI： 10.1093/jpids/piw001

Source DB:  PubMed          Journal:  J Pediatric Infect Dis Soc        ISSN： 2048-7193            Impact factor:   3.164


  10 in total

1.  Histoplasmosis in pregnancy: case series and report of transplacental transmission.

Authors:  Stevan P Whitt; George A Koch; Belinda Fender; Nathaniel Ratnasamy; E Dale Everett
Journal:  Arch Intern Med       Date:  2004-02-23

2.  Chicken pox infection in a three months old infant exposed in utero to Adalimumab.

Authors:  Anna Johnsson; Sara Avlund; Anne Grosen; Mette Julsgaard
Journal:  J Crohns Colitis       Date:  2012-08-09       Impact factor: 9.071

3.  A human immunodeficiency virus-positive infant with probable congenital histoplasmosis in a nonendemic area.

Authors:  Brian Alverson; Nicole Alexander; Mark P LeGolvan; Whitney Dunlap; Carly Levy
Journal:  Pediatr Infect Dis J       Date:  2010-11       Impact factor: 2.129

4.  Case Report: Fatal case of disseminated BCG infection in an infant born to a mother taking infliximab for Crohn's disease.

Authors:  Kuldeep Cheent; Jonathan Nolan; Sohail Shariq; Liina Kiho; Arabinda Pal; Jayantha Arnold
Journal:  J Crohns Colitis       Date:  2010-06-09       Impact factor: 9.071

5.  Disseminated histoplasmosis: clinical and pathologic correlations.

Authors:  R A Goodwin; J L Shapiro; G H Thurman; S S Thurman; R M Des Prez
Journal:  Medicine (Baltimore)       Date:  1980-01       Impact factor: 1.889

Review 6.  The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organisation: pregnancy and pediatrics.

Authors:  Uma Mahadevan; Salvatore Cucchiara; Jeffrey S Hyams; Flavio Steinwurz; F Nuti; Simon P L Travis; William J Sandborn; Jean-Frederio Colombel
Journal:  Am J Gastroenterol       Date:  2010-12-14       Impact factor: 10.864

7.  Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America.

Authors:  L Joseph Wheat; Alison G Freifeld; Martin B Kleiman; John W Baddley; David S McKinsey; James E Loyd; Carol A Kauffman
Journal:  Clin Infect Dis       Date:  2007-08-27       Impact factor: 9.079

8.  Placental transfer of anti-tumor necrosis factor agents in pregnant patients with inflammatory bowel disease.

Authors:  Uma Mahadevan; Douglas C Wolf; Marla Dubinsky; Antoine Cortot; Scott D Lee; Corey A Siegel; Thomas Ullman; Sarah Glover; John F Valentine; David T Rubin; Jocelyn Miller; Maria T Abreu
Journal:  Clin Gastroenterol Hepatol       Date:  2012-11-28       Impact factor: 11.382

9.  Histoplasmosis during childhood.

Authors:  J C Butler; R Heller; P F Wright
Journal:  South Med J       Date:  1994-04       Impact factor: 0.954

10.  Histoplasmosis in Patients With Cell-Mediated Immunodeficiency: Human Immunodeficiency Virus Infection, Organ Transplantation, and Tumor Necrosis Factor-α Inhibition.

Authors:  Keith Luckett; J Stephen Dummer; Geraldine Miller; Sydney Hester; Lora Thomas
Journal:  Open Forum Infect Dis       Date:  2015-02-20       Impact factor: 3.835
  10 in total
  2 in total

1.  Intrauterine Exposure to Biologics in Inflammatory Autoimmune Diseases: A Systematic Review.

Authors:  N Ghalandari; R J E M Dolhain; J M W Hazes; E P van Puijenbroek; M Kapur; H J M J Crijns
Journal:  Drugs       Date:  2020-11       Impact factor: 9.546

Review 2.  Histoplasmosis in Children; HIV/AIDS Not a Major Driver.

Authors:  Bassey E Ekeng; Kevin Edem; Ikechukwu Amamilo; Zachary Panos; David Denning; Rita O Oladele
Journal:  J Fungi (Basel)       Date:  2021-06-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.